APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS
Anemia is one of the most frequent complications arising in patients with malignant growths, it is characterized by reduction of hemoglobin level and disturbance of a number of physiological and metabolic processes in the organism, impairing the course of the disease and patients’ life quality. The...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Remedium Group LLC
2016-12-01
|
| Serija: | Медицинский совет |
| Teme: | |
| Online pristup: | https://www.med-sovet.pro/jour/article/view/1404 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|